On Wednesday, June 26th, 4G Clinical co-founders David Kelleher and Ed Tourtellotte were recognized as finalists for EY’s Entrepreneur Of The Year ®2019 Award for the New England region. An impressive group of unstoppable entrepreneurs from 36 companies across many industries celebrated entrepreneurship throughout the evening at the Westin Waterfront hotel in Boston.
Widely considered one of the most prestigious business awards programs in the U.S., this program recognizes entrepreneurs and leaders of high-growth companies who are excelling in areas such as innovation, financial performance and personal commitment to their businesses and communities, while also transforming our world.
While they didn’t walk away with the coveted award, the significance of being named a finalist is a credit to the amazing team at 4G Clinical that dedicates every day to bringing crucial medicines to those who need them, faster – a team that understands the criticality of their responsibility for the work that we do.
4G Clinical controls four major things in a clinical trial that all impact humans including the randomization scheme, clinical drug supply to sites, patient dosing and securing the blind. Two of those four can hurt people by either not having drug when needed or by mis-dosing. The other two can compromise trial results, costing pharmaceutical companies millions and jeopardizing a promising treatment. That responsibility is not taken lightly by anyone at 4G.
Congratulations to Brammer Bio for winning the Pharmaceutical Services category Wednesday night. If you are not familiar with their work, they are an impactful CMO focused on the exciting field of cell and gene therapies.
As a part of the process, EY developed a short vignette about Dave and Ed, and their work at 4G Clinical. You can view it here: